(Q46733753)

24 December 2017

title

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure (English)

1 reference

24 December 2017

0 references

0 references

Y Muto

1

1 reference

24 December 2017

K T Nouri-Aria

2

1 reference

24 December 2017

A Meager

3

1 reference

24 December 2017

G J Alexander

4

1 reference

24 December 2017

A L Eddleston

5

1 reference

24 December 2017

R Williams

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

24 December 2017

published in

The Lancet

1 reference

24 December 2017

volume

2

1 reference

24 December 2017

issue

8602

1 reference

24 December 2017

page(s)

72-74

1 reference

24 December 2017

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Lymphokines and monokines in the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Role of mononuclear infiltrating cells in pathogenesis of hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990006-2

7 January 2021

10.1016/S0140-6736(88)90006-2

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017